Bioptik Technology Incorporation (TPEX:4161)
18.70
-0.85 (-4.35%)
Nov 20, 2026, 1:30 PM CST
TPEX:4161 Revenue
Bioptik Technology Incorporation had revenue of 194.03M TWD in the quarter ending September 30, 2026, a decrease of -9.82%. This brings the company's total for the last twelve months to 891.73M, up 7.54% year-over-year. In the year 2025, Bioptik Technology Incorporation had annual revenue of 837.19M, down -3.25%. That makes Bioptik Technology Incorporation the 32,072nd largest company in the world by revenue and 1,649th in Taiwan.
Revenue (ttm)
891.73M
Revenue Growth
+7.54%
P/S Ratio
1.25
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.12B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full TPEX:4161 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 837.19M | -28.14M | -3.25% |
| Dec 31, 2024 | 865.34M | 36.83M | 4.45% |
| Dec 31, 2023 | 828.50M | 60.75M | 7.91% |
| Dec 31, 2022 | 767.75M | 29.86M | 4.05% |
| Dec 31, 2021 | 737.89M | 252.29M | 51.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.82B |
| OK Biotech | 1.72B |
| AViTA | 1.05B |
| Medimaging Integrated Solution | 744.42M |
| Radiant Innovation | 417.97M |
| Wiltrom | 314.12M |
| S&S Healthcare Holding | 185.52M |
| Taiwan Biomaterial | 153.37M |